MAM
Suzlon powers a new brand initiative – p.a.l.s.
MUMBAI: Wind power company, Suzlon, has launched a new brand campaign called p.a.l.s. – the Pure Air Lovers‘ Society.
The company has roped in radio jockey Malishka; model and actor Milind Soman; actor, social worker, and author Gerson da Cunha; and writer and columnist Anil Dharker, as the first p.a.l.s. champions.
P.a.l.s. aims to emphasise that clean air, green open spaces and proper channels of garbage disposal all lead to an improved quality of living. With a national print and TV campaign, the movement aims to gain traction through online registrations at www.pals.in.
Suzlon Group global head of brand Dharini Mishra said, “At Suzlon, we want to go beyond our corporate duties and dispel apathy to create social consciousness on environmental change. Working towards this, we initiated p.a.l.s. – a group of environmentally responsible individuals, who not only voice their opinions against the constant threat to our environment, but follow through in their actions. We believe that p.a.l.s. will create a change in attitudes, and eventually actions, to make our air cleaner and environment healthier.”
Lowe Lintas chairman R Balki said, “We are proud to partner with Suzlon to create a campaign that is critical and relevant to the times we live in. We believe that the p.a.l.s. movement will resonate with the people of India, educating and empowering them to make choices that have a direct impact on our planet.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
